Abstract: A zinc oxide nanocomposition is modified with a homobifunctional imidoester compound and an antibiotic composition contains the zinc oxide nanocomposition as an active ingredient. Also, a combination preparation contains the zinc oxide nanocomposite and an antifungal agent. The zinc oxide nanocomposite provides an antibiotic composition which is less toxic while exhibiting excellent antibiotic activity, for example, antiviral, antibacterial or antifungal activity. The antibiotic composition is usable to prevent contamination or infection by viruses, bacteria or fungi, inhibit the growth of viruses, bacteria or fungi, or treat infections by viruses, bacteria or fungi.

Abstract: A method for defending against an adversarial sample in image classification includes: denoising, by an adversarial denoising network, an input image to acquire a reconstructed image; acquiring, by a target classification model, a predicted category probability distribution of the reconstructed image; acquiring, by the target classification model, a predicted category probability distribution of the original input image; calculating an adversarial score of the input image, and determining the input image as an adversarial sample or a benign sample according to a threshold; outputting a category prediction result of the reconstructed image if the input image is determined as the adversarial sample; and outputting a category prediction result of the original input image if the input image is determined as the benign sample. A system for defending against an adversarial sample in image classification, and a data processing terminal are further provided.

Abstract: Products, compositions, systems, and methods for modifying a target structure which mediates or is associated with a biological activity, including treatment of conditions, disorders, or diseases mediated by or associated with a target structure, such as a virus, cell, subcellular structure or extracellular structure. The methods may be performed in situ in a non-invasive manner by application of an initiation energy to a subject thus producing an effect on or change to the target structure directly or via a modulation agent. The methods may further be performed by application of an initiation energy to a subject in situ to activate a pharmaceutical agent directly or via an energy modulation agent, optionally in the presence of one or more plasmonics active agents, thus producing an effect on or change to the target structure. Kits containing products or compositions formulated or configured and systems for use in practicing these methods.

Abstract: An apparatus includes a rotating pole, a first set of photovoltaic modules; and a second set of photovoltaic modules. The second set of photovoltaic modules do not rotate with the rotating pole.

Abstract: Disclosed herein is a simple method for generation of high-throughput aerosols of monodisperse micro-shell particles. To create the aerosol, small nozzles are employed blowing slightly compressed air on a thin liquid film. This allows one to generate bubble aerosols consisting of particles having a thin liquid shell surrounding a gas core, which are suspended in a carrier gas flow or environment. The diameter of the created liquid shells is uniform and scales with the inner diameter of the blowing nozzle, enabling control on the size of the produced monodispersed aerosol and formation of particles between few microns to several hundred of microns in outer diameter. The process throughput is very high, reaching several thousands of particles with liquid micro-shells per second for one blowing nozzle.

Abstract: Non-human animal compression therapy devices and methods. In some embodiments, the compression therapy devices includes one or more sleeves, each of the one or more sleeves being configured to fit a limb of a non-human animal, and each of the one or more sleeves comprising one or more inflatable chambers; and a controllable air source operably connected with the one or more inflatable chambers and configured to controllably inflate and deflate the one or more inflatable chambers. In some embodiments, at least one cycle of inflating and deflating of the one or more chambers starts by inflating the most distal chamber. In some embodiments, the compression therapy is given to eliminate or ease suffering from a disease or disorder or a sporting or work-related injury.

Abstract: Disclosed herein, inter alia, are compounds, compositions, and methods of use thereof in the sequencing a nucleic acid.

Abstract: Apparatus include a mode-locked laser cavity configured to produce a mode-locked output beam, wherein the laser cavity includes a gain medium situated in the laser cavity and an intracavity optical coating filter situated in the laser cavity to receive an intracavity beam, wherein the intracavity optical coating filter has an attenuation profile configured to suppress laser oscillation over a selected portion of the gain bandwidth of the gain medium and to increase a bandwidth of the mode-locked output beam based on the suppression. Related optical coatings are disclosed. Methods of arranging coatings and reducing pulse duration are also disclosed.

Abstract: Aspects of the disclosure provide a method for denoising an image. The method can include receiving an acquired image from an image acquisition system, and processing the acquired image with a nonlinear diffusion coefficient based filter having a diffusion coefficient that is calculated using gradient vector orientation information in the acquired image.

Abstract: Metal complexes with ligands bearing a five member aromatic moiety fused with dibenzofuran or its analogues useful as electroluminescence materials in OLEDs are disclosed.

Abstract: Aspects of self-powered weigh-in-motion systems and methods that utilize piezoelectric components for sensing load as well as powering data acquisition and analysis components. In one example, the weigh-in-motion system includes a number of piezoelectric stacks, each stack including a number of piezoelectric elements. Each stack includes one or more top or upper piezoelectric element that provides vehicle sensing data. Each stack also includes a set of piezoelectric elements used for energy harvesting. The sensing piezoelectric elements are connected to a data input of a microcontroller for vehicle classification, while the energy harvesting piezoelectric elements are connected to a power input of the microcontroller.

Abstract: A pressure sensor system is provided. In another aspect, a wireless intraocular pressure sensor includes a deformable or stretchable inductor. A further aspect of an intraocular pressure sensing system includes a deformable inductor sized to contact an eye. Another aspect provides an organ pressure sensing system including a passive inductor with a wavy, serpentine or undulating shape.

Abstract: A transistor-type sensor capable of detecting a compound having an amino group has a simple structure and also is expected to be effective in antioxidation action and prevention of dementia, etc. The transistor-type sensor includes a detection electrode for capturing a compound having an amino group for detection, and a transistor having a gate electrode connected with the detection electrode. The detection electrode has a cucurbituril structure-containing compound immobilized on the surface thereof.

Abstract: This present disclosure relates to the use of syncytiotrophoblast-derived microvesicles for diagnosing and/or monitoring a subject with preeclampsia. Accordingly, this disclosure provides for methods for isolating, purifying, and/or detecting syncytiotrophoblast-derived microvesicles from a biological fluid of a pregnant subject. The present disclosure also provides kits for diagnosing a subject with preeclampsia, where the kit contains reagents useful for isolating, purifying, and/or identifying the syncytiotrophoblast-derived microvesicles in a biological sample and for detecting one or more biomarkers present on the surface of or within the syncytiotrophoblast-derived microvesicles.

Abstract: Safety certification of cyber-physical system (CPS) such as autonomous cars or medical control systems are complicated especially due to the lack of transparency between the manufacturer and certifying authority. The manufacturer has significant restrictions in sharing knowledge with the certification authority. Further, given time constraints, it may not be feasible for the certification authority to examine internal details of the CPS. A system models the safety certification of CPS as an agile iterative game, where a manufacturer agent acting on behalf of the manufacturer and a certifier agent acting on behalf of a third-party certification entity aims to find an optimal subset of operating data to share for accurate safety certification. The certification agent, armed with CPS model mining methods and safety assessment analysis tools, aims to accurately assess safety of the CPS with the information shared.

Abstract: A compound comprising a first ligand LA of Formula I is described. In Formula I, X1 and X6 to X10 are each independently C or N; X2 is CR1? or N; X3 is CR1 or N; X4 is CR2 or N; X5 is CR3 or N; each R1, R2, R3, RA, RB, and RC is independently a hydrogen or a General Substituent; any two substituents may be joined or fused to form a ring; at least one of R1?, R1, R2, and R3 is a partially or fully deuterated alkyl or cycloalkyl group; at least one pair of RC are joined or fused to form a 5-membered or 6-membered ring. Formulations, OLEDs, and consumer products comprising the compound are also described.

Abstract: The present disclosure relates to methods and compositions for elevating and stabilizing retromer for treating and/or preventing Alzheimer's disease and other neurodegenerative disorders. Additionally, the disclosure relates to adenoviral based therapy for treating Alzheimer's disease (AD), and other neurodegenerative conditions such as Parkinson's Disease (PD), neuronal ceroid lipofuscinosis (NCL), and transmissible spongiform encephalopathies (TSEs or prion disease), multiple system atrophy (MSA), Down's syndrome, and hereditary spastic paraplegia, as well as tauopathies such as progressive supranuclear palsy (PSP), frontotemporal lobar dementia linked to chromosome 17q21-22 and its subtypes (FTLD-17/FTLD-Tau), Lewy Body Disease (LBD), amyotrophic lateral sclerosis (ALS), frontal-temporal degeneration (FTD), ALS-FTD, and chronic traumatic encephalopathy (CTE).

Abstract: Aspects of the disclosure provide a method for denoising an image. The method can include receiving an acquired image from an image acquisition system, and processing the acquired image with a nonlinear diffusion coefficient based filter having a diffusion coefficient that is calculated using gradient vector orientation information in the acquired image.

Abstract: Provided is a method of using an aptamer for detecting a glycated hemoglobin in a whole blood, the method includes that the aptamer is provided, the aptamer includes a DNA sequence selected from the group consisting of derived sequences of SEQ ID NOs: 1, 2, 3, and 4, in which the derived sequences refer to that 3? end and/or 5? end of the derived sequences are modified, and the derived sequences have 90% identity to the SEQ ID NOs: 1, 2, 3, and 4. The aptamer and the whole blood are contacted. A concentration of a conjugate of the aptamer and the glycated hemoglobin is estimated. Provided also is a nanoelectronic aptasensor including the above aptamer.

Abstract: Carbon materials formed using various templates of precursor materials are described in addition to method and process for producing the same.